Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.

PubWeight™: 3.62‹?› | Rank: Top 1%

🔗 View Article (PMC 326485)

Published in Nucleic Acids Res on November 11, 1983


T Shioda, Y Hidaka, T Kanda, H Shibuta, A Nomoto, K Iwasaki

Articles citing this

The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38

A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A (1991) 3.15

Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82

Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med (2004) 2.80

The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71

Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60

Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol (1990) 2.50

Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. Proc Natl Acad Sci U S A (1986) 2.36

Modified model for the switch from Sendai virus transcription to replication. J Virol (1989) 2.32

The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript. J Virol (1985) 2.15

Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol (1986) 1.78

Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75

RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol (1990) 1.68

The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61

Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59

Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58

Sequence homology within the morbilliviruses. J Virol (1985) 1.56

The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly. J Virol (1993) 1.55

The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol (1998) 1.52

Analysis of the Sendai virus M gene and protein. J Virol (1984) 1.46

Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. J Virol (1986) 1.42

Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol (1991) 1.35

Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34

The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol (2003) 1.33

Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30

Ribosomal initiation at alternate AUGs on the Sendai virus P/C mRNA. J Virol (1986) 1.26

Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication. J Virol (1988) 1.24

Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo. J Virol (1989) 1.22

Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16

Leader sequence distinguishes between translatable and encapsidated measles virus RNAs. J Virol (1990) 1.13

"Rule of six": how does the Sendai virus RNA polymerase keep count? J Virol (2001) 1.08

mRNA sequence of three respiratory syncytial virus genes encoding two nonstructural proteins and a 22K structural protein. J Virol (1985) 1.07

Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. J Virol (1999) 1.05

Proteins associated with human parainfluenza virus type 3. J Virol (1985) 1.04

Sequence analysis of the respiratory syncytial virus phosphoprotein gene. J Virol (1984) 1.03

Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J Virol (1991) 1.02

Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol (2000) 1.02

Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02

Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J Virol (1994) 1.01

Nucleotide sequences that affect replicative and transcriptional efficiencies of Sendai virus deletion mutants. J Virol (1986) 0.99

3'-Terminal sequence of human parainfluenza virus 3 genomic RNA. Nucleic Acids Res (1986) 0.96

Nucleotide sequence analysis of the L gene of Newcastle disease virus: homologies with Sendai and vesicular stomatitis viruses. Nucleic Acids Res (1987) 0.95

Biology of parainfluenza viruses. Clin Microbiol Rev (1994) 0.95

The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. Nucleic Acids Res (1994) 0.93

Interferon induction by transfection of Sendai virus C gene cDNA. J Virol (1987) 0.91

Expression of five proteins from the Sendai virus P/C mRNA in infected cells. J Virol (1989) 0.91

Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally. J Virol (2002) 0.90

Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein. Nucleic Acids Res (1986) 0.89

Cloning and sequencing of the polymerase gene (P) of Sendai virus (strain Fushimi). Nucleic Acids Res (1989) 0.81

Expression of Sendai virus nucleocapsid protein in a baculovirus expression system and application to diagnostic assays for Sendai virus infection. J Clin Microbiol (1995) 0.80

Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol (1991) 0.78

An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis. J Virol (1997) 0.78

Cloning and sequencing of the matrix protein gene (M) of Sendai virus (strain Fushimi). Nucleic Acids Res (1990) 0.77

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70

Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A (1979) 72.18

Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation event. Biochemistry (1970) 26.22

The analysis of nucleic acids in gels using glyoxal and acridine orange. Methods Enzymol (1980) 10.84

Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol (1981) 7.97

Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32

Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol (1981) 4.49

Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50

Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06

Genetic studies with heteroduplex DNA of bacteriophage fl. Asymmetric segregation, base correction and implications for the mechanism of genetic recombination. J Mol Biol (1975) 2.95

Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60

Molecular weight determination of Sendai and Newcastle disease virus RNA. J Virol (1974) 2.45

Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded. J Virol (1975) 2.42

Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17

Regulation of Sendai virus transcription: evidence for a single promoter in vivo. J Virol (1977) 2.02

Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87

Molecular cloning of the 3'-proximal third of Sendai virus genome. Proc Natl Acad Sci U S A (1983) 1.73

Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68

Conserved polyadenylation signals in two negative-strand RNA virus families. Virology (1982) 1.64

The complete sequence and coding content of snowshoe hare bunyavirus small (S) viral RNA species. Nucleic Acids Res (1982) 1.61

Comparison of the sequences and coding of La Crosse and snowshoe hare bunyavirus S RNA species. J Virol (1983) 1.59

Complete nucleotide sequence of the nucleoprotein gene from the human influenza strain A/PR/8/34 (HON1). Eur J Biochem (1981) 1.49

Sequences of vesicular stomatitis virus RNA in the region coding for leader RNA, N protein mRNA, and their junction. Proc Natl Acad Sci U S A (1979) 1.48

Sequence analysis of the polymerase 1 gene and the secondary structure prediction of polymerase 1 protein of human influenza virus A/WSN/33. J Virol (1982) 1.46

Mouse hepatitis virus (MHV-2). Plaque assay and propagation in mouse cell line DBT cells. Jpn J Microbiol (1976) 1.43

In vitro synthesis of the nonstructural C protein of Sendai virus. J Virol (1983) 1.29

Isolation of RNA transcripts from the entire Sendai viral genome. J Virol (1975) 1.29

Genomic and copy-back 3' termini in Sendai virus defective interfering RNA species. J Virol (1983) 1.28

Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Jpn J Exp Med (1967) 1.19

Restriction map of double-stranded DNA copy synthesized from poliovirus Sabin 1 RNA. J Biochem (1982) 1.18

Comparison of the nucleotide sequences at the 3'-terminal region of RNAs from RNA coliphages. J Mol Biol (1982) 1.07

Mononucleotide and dinucleotide frequencies, and codon usage in poliovirion RNA. Nucleic Acids Res (1981) 1.04

A temperature-sensitive mutant of Sendai virus which establishes persistent infection in Vero cells without cell crisis. Virology (1981) 0.90

A proposal for designation of Sendai virus proteins. Jpn J Microbiol (1975) 0.90

Articles by these authors

Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14

A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06

A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92

The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26

Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09

The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61

Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V(1). J Am Coll Cardiol (2001) 4.81

O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68

The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97

Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol (1986) 3.90

Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79

Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J (1990) 3.31

Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27

Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol (2000) 3.09

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98

NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J (2001) 2.94

N-linked oligosaccharides are not involved in the function of a cell-cell binding glycoprotein E-cadherin. Cell Struct Funct (1986) 2.90

Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87

Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol (1991) 2.87

Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J (1997) 2.84

Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81

Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet (1999) 2.71

Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63

Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60

Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55

Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Translation of the genetic message. VII. Role of initiation factors in formation of the chain initiation complex with Escherichia coli ribosomes. Arch Biochem Biophys (1968) 2.46

RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38

Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation (2001) 2.36

Three-step method for ultrasound-guided central vein catheterization. Br J Anaesth (2012) 2.35

Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol (1986) 2.28

In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26

Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24

Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19

Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17

Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol (1989) 2.17

Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14

ParaSight-F test for the detection of treatment failure in multidrug resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1996) 2.13

In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10

Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07

Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother (1989) 2.05

The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99

The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89

Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region. J Mol Biol (1979) 1.87

Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol (1999) 1.86

Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol (1997) 1.81

X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev Biol (2000) 1.80

Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation. Mol Cell Biol (2001) 1.79

Transformation-defective mutants of Rous sarcoma virus with longer sizes of genome RNA and their highly frequent occurrences. J Virol (1979) 1.78

A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J Pathol (2008) 1.78

Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77

Schwannoma of the esophagus: a case exhibiting high 18F-fluorodeoxyglucose uptake in positron emission tomography imaging. Dis Esophagus (2009) 1.75

A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70

The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem (2000) 1.70

Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest (1994) 1.69

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A (1997) 1.68

Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome. J Gen Virol (1979) 1.68

Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68

Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol (1999) 1.66

Determination of functional domains in polypyrimidine-tract-binding protein. Biochem J (1998) 1.63

Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63

Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62

Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X. J Virol (1997) 1.61

Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element. Circ Res (2001) 1.61

An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61

Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J (2002) 1.60

Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res (1997) 1.60

Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med (1995) 1.59

Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol (1998) 1.59

Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58

A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol (1988) 1.58

Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 1.56

In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55

Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1. J Virol (1989) 1.54

Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev (2001) 1.53

Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol (1991) 1.53

Mutational analysis of human papillomavirus type 16 E7 functions. J Virol (1990) 1.52

Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res (2006) 1.52

Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J (2000) 1.51

Therapeutic controversy: Screening for postpartum thyroiditis. J Clin Endocrinol Metab (1999) 1.50

Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol (1989) 1.50

Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications (2001) 1.49

CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49

T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int (2008) 1.48

Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology (1998) 1.47

Adhesion of single application bonding systems to bovine enamel and dentin. Oper Dent (2002) 1.47

Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem (1994) 1.47

Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab (1995) 1.46

Determination of antipituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysis. J Lab Clin Med (1998) 1.46